Metabolic Reprogramming of Immune Cells in Cancer Progression

被引:478
|
作者
Biswas, Subhra K. [1 ]
机构
[1] ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore
关键词
TUMOR-ASSOCIATED MACROPHAGES; RECEPTOR TYROSINE KINASES; HYPOXIA-INDUCIBLE FACTORS; NITRIC-OXIDE SYNTHASE; HUMAN DENDRITIC CELLS; SUPPRESSOR-CELLS; REGULATORY T; MYELOID CELLS; LACTIC-ACID; TRANSCRIPTIONAL REGULATION;
D O I
10.1016/j.immuni.2015.09.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immune cells play a key role in host defense against infection and cancer. Upon encountering danger signals, these cells undergo activation leading to a modulation in their immune functions. However, recent studies reveal that immune cells upon activation also show distinct metabolic changes that impact their immune functions. Such metabolic reprogramming and its functional effects are well known for cancer cells. Given that immune cells have emerged as crucial players in cancer progression, it is important to understand whether immune cells also undergo metabolic reprogramming in tumors and how this might affect their contribution in cancer progression. This emerging aspect of tumor-associated immune cells is reviewed here, discussing metabolic reprogramming of different immune cell types, the key pathways involved, and its impact on tumor progression.
引用
收藏
页码:435 / 449
页数:15
相关论文
共 50 条
  • [1] Metabolic reprogramming of immune cells in pancreatic cancer progression
    Xiang, Hong
    Yang, Runjuan
    Tu, Jiaxin
    Xi, Yan
    Yang, Shilei
    Lv, Linlin
    Zhai, Xiaohan
    Zhu, Yanna
    Dong, Deshi
    Tao, Xufeng
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2023, 157
  • [2] Metabolic reprogramming and cancer progression
    Faubert, Brandon
    Solmonson, Ashley
    DeBerardinis, Ralph J.
    [J]. SCIENCE, 2020, 368 (6487) : 152 - +
  • [3] Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis
    Ohshima, Kenji
    Morii, Eiichi
    [J]. METABOLITES, 2021, 11 (01) : 1 - 23
  • [4] Metabolic reprogramming and kidney cancer progression
    DeBerardinis, Ralph J.
    [J]. CANCER RESEARCH, 2023, 83 (16)
  • [5] Editorial: Metabolic reprogramming and cancer progression
    Yin, Qinan
    Poudel, Nabin
    Liu, Ziyi
    [J]. TRANSLATIONAL ONCOLOGY, 2023, 28
  • [6] Metabolic reprogramming and cancer progression in patients
    DeBerardinis, Ralph J.
    [J]. CANCER RESEARCH, 2024, 84 (05)
  • [7] The cancer metabolic reprogramming and immune response
    Xia, Longzheng
    Oyang, Linda
    Lin, Jinguan
    Tan, Shiming
    Han, Yaqian
    Wu, Nayiyuan
    Yi, Pin
    Tang, Lu
    Pan, Qing
    Rao, Shan
    Liang, Jiaxin
    Tang, Yanyan
    Su, Min
    Luo, Xia
    Yang, Yiqing
    Shi, Yingrui
    Wang, Hui
    Zhou, Yujuan
    Liao, Qianjin
    [J]. MOLECULAR CANCER, 2021, 20 (01)
  • [8] The cancer metabolic reprogramming and immune response
    Longzheng Xia
    Linda Oyang
    Jinguan Lin
    Shiming Tan
    Yaqian Han
    Nayiyuan Wu
    Pin Yi
    Lu Tang
    Qing Pan
    Shan Rao
    Jiaxin Liang
    Yanyan Tang
    Min Su
    Xia Luo
    Yiqing Yang
    Yingrui Shi
    Hui Wang
    Yujuan Zhou
    Qianjin Liao
    [J]. Molecular Cancer, 20
  • [9] Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy
    Nicolini, Andrea
    Ferrari, Paola
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [10] Metabolic reprogramming and disease progression in cancer patients
    Torresano, Laura
    Nuevo-Tapioles, Cristina
    Santacatterina, Fulvio
    Cuezva, Jose M.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (05):